findmyKOL

Seenu Hariprasad, MD

Enriched profile

Chair, Department of Ophthalmology and Visual Science; Shui-Chin Lee Professor of Ophthalmology and Visual Science; Chief, Vitreoretinal Service · University of Chicago Medicine & Biological Sciences

ORCIDNPI
Region🇺🇸 Chicago, IL · Midwest · United StatesSpecialtyOphthalmologyFocusRetinal Diseases and Treatments+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Seenu Hariprasad is Chair, Department of Ophthalmology and Visual Science; Shui-Chin Lee Professor of Ophthalmology and Visual Science; Chief, Vitreoretinal Service at University of Chicago Medicine & Biological Sciences. OpenAlex indexes 284 publications with 5,842 citations (h-index 33); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Seenu Mavidi Hariprasad is Chair, Department of Ophthalmology and Visual Science at University of Chicago Medicine & Biological Sciences. The public record shows 284 publications with 5,842 citations (h-index 33), centered on Retinal Diseases and Treatments, Retinal Imaging and Analysis, Retinal and Optic Conditions. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 23 companies.

  • Most recent indexed publication: 2023 · Clinical transplantation
  • Top research focus: Retinal Diseases and Treatments
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 23 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Cataract1 trialEndophthalmitis1 trialMacular Degeneration (AMD)Glaucoma

Research focus

OpenAlex concept fingerprint
Retinal Diseases and TreatmentsRetinal Imaging and AnalysisRetinal and Optic ConditionsRetinal and Macular SurgeryGlaucoma and retinal disorders

Drugs & molecules

across trials, industry payments and publications
Yutiqgeneric · FluocinoloneClinical trialsIndustry payments83Publications1Cimerligeneric · RanibizumabClinical trialsIndustry payments49Publications1Eyleageneric · AfliberceptClinical trialsIndustry payments244Publications

Works with

trial sponsors and companies reporting payments
Regeneron Healthcare Solutions, Inc.Clinical trialsIndustry payments412Astellas Pharma US IncClinical trialsIndustry payments131Abbvie Inc.Clinical trialsIndustry payments86

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
284publications

Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.

5,842citations

Total citations across indexed works.

33h-index

Hirsch index (OpenAlex). i10-index 99.

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials
23companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

23 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    100%
    Vascular Endothelial Growth Factor Inhibitor100%
    Bevacizumab100%
    Part B, office-administered23 patients
Where care is delivered (Part B)83% facility · 17% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/seenu-hariprasad-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • Other

    profiles.uchicago.edu/profiles/display/37966

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.uchicago.edu
  • ResearchGate

    researchgate.net/scientific-contributions/Seenu-M-Hariprasad-38368001

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net
1 more verified account behind the reveal.Reveal →

Mentions by others

where others cite or feature them
  • Facebook

    m.facebook.com/uchicago.ophthalmology/photos/in-the-latest-asrs-section-member-news-chair-dr-seenu-hariprasad-md-discusses-ho/1648280189298552

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →m.facebook.com
  • X / Twitter

    x.com/UChicagoOVS/status/1853903342105419946

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com
  • Journals.elsevier.com

    American Journal of Ophthalmology editorial board member

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →journals.elsevier.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Perelman School of Medicine, University of Pennsylvania

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ophthalmology.uchicago.edu
  • Transitional Internship

    Baylor College of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ophthalmology.uchicago.edu
  • Residency in Ophthalmology

    Cullen Eye Institute, Baylor College of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ophthalmology.uchicago.edu
  • Fellowship in Retina

    Barnes Retina Institute, Washington University in St. Louis

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ophthalmology.uchicago.edu

Editorial & leadership roles

journal and society appointments
  • Chair

    Department of Ophthalmology and Visual Science, University of Chicago

    2023
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biologicalsciences.uchicago.edu
  • Chief

    Vitreoretinal Service, University of Chicago Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org
  • Director

    Clinical Research, University of Chicago Medicine Department of Ophthalmology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org
1 more role behind the reveal.Reveal →

Awards & honors

honors on the public record
1 more award behind the reveal.Reveal →

Media & interviews

press, podcasts and appearances
1 more media item behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.